Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
37M
-
Shares change
-
+6.21M
-
Total reported value, excl. options
-
$1.68B
-
Value change
-
+$285M
-
Put/Call ratio
-
0.17
-
Number of buys
-
98
-
Number of sells
-
-44
-
Price
-
$45.30
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q2 2020
160 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q2 2020.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37M shares
of 60.4M outstanding shares and own 61.29% of the company stock.
Largest 10 shareholders include JPMORGAN CHASE & CO (3.13M shares), BlackRock Inc. (2.87M shares), Invesco Ltd. (1.97M shares), VANGUARD GROUP INC (1.66M shares), ARK Investment Management LLC (1.64M shares), FMR LLC (1.6M shares), STATE STREET CORP (1.6M shares), Tao Capital Management LP (1.32M shares), WELLINGTON MANAGEMENT GROUP LLP (1.25M shares), and Casdin Capital, LLC (1M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.